Opendata, web and dolomites

Breakborder SIGNED

Breaking borders, Functional genetic screens of structural regulatory DNA elements

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 Breakborder project word cloud

Explore the words cloud of the Breakborder project. It provides you a very rough idea of what is the project "Breakborder" about.

types    distinguish    toolbox    underlying    mammalian    strategy    genome    pattern    screens    3d    induction    players    recruit    strategies    cancer    architecture    proliferation    insulators    expression    cellular    carries    mechanisms    magnitude    dna    plan    outlined    rdes    impeding    parallel    structural    postulated    datasets    natural    altogether    principles    functional    scientific    insulate    setting    tumour    indispensable    regulation    screening    effectivity    structure    regions    acquired    crispr    successful    interestingly    cell    aberrations    understand    progress    extension    expanded    decipher    therapy    line    enhancers    showed    homeostasis    setup    human    resistance    differentiation    tools    occurring    validate    survival    oncogenic    regulatory    phenotypes    suppressive    scalability    transcription    lacking    editing    genes    gene    genetic    technologies    transcribed    action    chromatin    opened    forms    sequencing    organismal    metastasis    examine    nevertheless    foundation    transcriptional   

Project "Breakborder" data sheet

The following table provides information about the project.

Coordinator
STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN LEEUWENHOEK ZIEKENHUIS 

Organization address
address: PLESMANLAAN 121
city: AMSTERDAM
postcode: 1066 CX
website: www.nki.nl

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Netherlands [NL]
 Total cost 2˙497˙000 €
 EC max contribution 2˙497˙000 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2018-ADG
 Funding Scheme ERC-ADG
 Starting year 2019
 Duration (year-month-day) from 2019-09-01   to  2024-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN LEEUWENHOEK ZIEKENHUIS NL (AMSTERDAM) coordinator 2˙497˙000.00

Map

 Project objective

The human genome carries genetic information in two distinct forms: Transcribed genes and regulatory DNA elements (rDEs). rDEs control the magnitude and pattern of gene expression, and are indispensable for organismal development and cellular homeostasis. Nevertheless, while large-scale functional genetic screens greatly advanced our knowledge in studying mammalian genes, such tools to study rDEs were lacking, impeding scientific progress. Interestingly, recent advance in genome editing technologies has not only expanded the available screening toolbox to examine genes, but also opened up novel opportunities in studying rDEs. We distinguish two types of rDEs: Transcriptional rDEs that recruit transcription factors to enhancers, and structural rDEs that maintain chromatin 3D structure to insulate transcriptional activities, a feature postulated to be essential for gene expression regulation by enhancers. Recently, we developed a CRISPR strategy to target enhancers. We showed its scalability and effectivity in identifying potential oncogenic and tumour-suppressive enhancers. Here, we will exploit this line of research and develop novel strategies to target structural rDEs (e.g. insulators). By setting up functional genetic screens, we will identify key players in cell proliferation, differentiation, and survival, which are related to cancer development, metastasis induction, and acquired therapy resistance. We will validate key insulators and decipher underlying mechanisms of action that control phenotypes. In a parallel approach, we will analyse whole genome sequencing datasets of cancer to identify and characterize genetic aberrations occurring in the identified regions. Altogether, the outlined research plan forms a natural extension of our successful functional approaches to study gene regulation. Our results will setup the foundation to better understand principles of chromatin architecture in gene expression regulation in development and cancer.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "BREAKBORDER" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "BREAKBORDER" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

iNANOVAC4CANCER (2019)

BIOHYBRID AND BIODEGRADABLE NANOVACCINES FOR CANCER IMMUNOTHERAPY

Read More  

DYNAPOL (2019)

Modeling approaches toward bioinspired dynamic materials

Read More  

MuFLOART (2018)

Microbiological fluorescence observatory for antibiotic resistance tracking

Read More